Annalisa Stilla

757 citations
8 papers · 612 indexed · h-index 7
Topics
PARP inhibition in cancer therapy (6 papers)Calcium signaling and nucleotide metabolism (5 papers)Toxin Mechanisms and Immunotoxins (4 papers)
Partner nations
ItalyGermanyFrance

In The Last Decade

Annalisa Stilla

8 papers receiving 595 citations

Peers

Annalisa Stilla
Comparison fields: 5 of 62
  • Immunology 315
  • Hepatology 266
  • Oncology 201
  • Epidemiology 200
  • Physiology 118
Replace Yoshiko Kobune with:
Yoshiko Kobune Japan
Harikesh S. Wong United States
Songqing Tang China
Dorine Bonte France
K Q Hu United States
Thomas F. Baumert France
Mohammed Dhalla Saudi Arabia
Kyle J. Seamon United States
Hideyuki Kato Japan
Hae Soo Park United States
Annalisa Stilla relative to Yoshiko Kobune Japan Yoshiko Kobune's profile →
Citations per field
00.5×10×16.6×
Yoshiko Kobune · 1×
Citations per year

Countries citing papers authored by Annalisa Stilla

Since Specialization
Citations

This map shows the geographic impact of Annalisa Stilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annalisa Stilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annalisa Stilla more than expected).

Fields of papers citing papers by Annalisa Stilla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annalisa Stilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annalisa Stilla. The network helps show where Annalisa Stilla may publish in the future.

Co-authorship network of co-authors of Annalisa Stilla

This figure shows the co-authorship network connecting the top 25 collaborators of Annalisa Stilla. A scholar is included among the top collaborators of Annalisa Stilla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annalisa Stilla. Annalisa Stilla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 8
2 48
3 7
4 11
5 2
6 94
7 81
8 361

About Annalisa Stilla

Annalisa Stilla is a scholar working on Physiology, Immunology and Oncology, having authored 8 papers that have together received 612 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (6 papers), Calcium signaling and nucleotide metabolism (5 papers) and Toxin Mechanisms and Immunotoxins (4 papers). The work is most often cited by research in Hepatology (266 citations), Physiology (118 citations) and Immunology (315 citations). Annalisa Stilla has collaborated with scholars based in Italy, Germany and France. Frequent co-authors include Maria Di Girolamo, Nadia Dani, Daniela Corda, Sergio Abrignani, Sandra Nuti, Stefania Crotta, Marta Mosca, Annalisa D’Andrea, Ferruccio Bonino and Ugo D’Oro. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026